Provention Bio Highlights Critical New Research Studies on Type One Diabetes

~ JDRF T1D Fund Study Estimates 2.3 Million People at Risk Globally to Develop Stage 3 T1D, Which Already Affects 18 Million People Globally ~ Journal of American Medicine Association Research Publication Finds Screening for T1D Significantly Reduces the Risk of Diabetic Ketoacidosis

Thank you for visiting Tailwinds Research. We are pleased to offer free research on select small and micro cap companies. It is free to join and we hope you’ll take the time to do so.

To create an account please click on this link.

If you already have an account, please log in here.